Supporting CML physicians in Africa. 

Meeting 1 - October 25 - The Realities of Treatment Free Remission in Low and Middle Income Countries and CML from the Laboratory

Hosts: Professor Tim Hughes (Australia), Professor Sue Branford (Australia), Dr Matilda Ong’ondi (Kenya) and Professor Lateef Salawu (Nigeria).

Part 1 of 2: The Realities of TFR in Low- and Middle-Income Countries

Part 2 of 2: From the Laboratory

Meeting 2 - November 29 - Pediatric CML – Key Issues in Treating Children and Young People with CML and The Impact of CML on Fertility and Pregnancy

Hosts: Oliver Henke (Tanzania), Amma Benneh (Ghana), Dr Maaike Leusink (Netherlands) & Elizabetta Abruzzese (Italy)

Part 1 of 2: Key Issues in Treating Children and Young People with CML

Part 2 of 2: The Impact of CML on Pregnancy and Fertility

Meeting 3 - December 27 - Challenging Scenarios in CML

Hosts: Professor Giuseppe Saglio (Italy), Professor Naeem Chaudhri (Saudi Arabia), Professor Amha Gebremedhin (Ethiopia) & Dr Olanrewaju Ochogwu (United Kingdom).

  Challenging Scenario 1: 24yo male in blast crisis at presentation

Challenging Scenario 2: 69yo male with resistance to treatment

Challenging Scenario 3: 47yo male with drug-related toxicities and thrombocytopenia

Challenging Scenario 4: Patient with financial restrictions does not respond to available treatment

Challenging Scenario 5: 29yo male lost to treatment for more than 10 months returns in blast crisis

Challenging Scenario 6: 37yo female does not respond to TKIs, develops TB uveitis post transplant

Challenging Scenario 7: 53yo male with atypical CML

If you have a challenging case you would like to ask CML expert's advice on please visit the iCMLf Clinical Case Discussion Forum

South Asia Regional Discussion Groups

Supporting CML physicians in South Asia. 

Registration for the 2024 series of Regional Discussion Groups is now live. You can find out more and register here.

Recordings from all three 2023 South Asian Discussions can now be seen by following the links below

Discussion 1: The Realities of Treatment Free Remission in Low and Middle Income Countries and CML From the Laboratory

Hosted by: Professor Susanne Saussele (Germany), Professor Nick Cross (UK), Professor Hemant Malhotra (India) and Dr Mipsang Lama (Nepal).

Part 1 of 2: Realities of TFR

 Part 2 of 2: CML From the Laboratory

Discussion 2: Challenging Cases in CML

Hosted By: Professor Mhairi Copland (UK), Professor Charles Schiffer (USA), Professor Raghunadharao Digumarti (India), Assistant Professor Stalin Chowdary Bala (India).

Case 1 of 5: 20yo female with treatment gaps and dual mutations

Case 2 of 5: 31yo female with multiple cytopenias

Case 3 of 5: 41yo male with dual mutations and thrombocytopenia on second-line TKI

Case 4 of 5: 25yo female with frequent treatment stops and limited support does not respond well to TKIs

Case 5 of 5: 40yo female with lymphoid blast crisis and dual mutations

Further Discussion:

Patents and the manufacture of medications in India for more affordable options
Allograft with haplo-match donors, especially in pediatric patients

Discussion 3: Pediatric CML – Key issues in treating children and young people with CML and The Impact of CML on fertility and pregnancy

Hosted by: Professor Meinolf Suttorp (Germany), Professor Gianantonio Rosti (Italy), Professor Nirmalya Roy Moulik (India) and Professor Zeba Aziz (Pakistan). 

Part 1 of 2: Treating CML in Children and Young People

Part 2 of 2: The Impact of CML on Pregnancy and Fertility